Ontology highlight
ABSTRACT:
SUBMITTER: Wedekind MF
PROVIDER: S-EPMC6153971 | biostudies-literature | 2018 Oct
REPOSITORIES: biostudies-literature
Wedekind Mary Frances MF Denton Nicholas L NL Chen Chun-Yu CY Cripe Timothy P TP
Paediatric drugs 20181001 5
Cancer immunotherapies, widely heralded as transformational for many adult cancer patients, are becoming viable options for selected subsets of pediatric cancer patients. Many therapies are currently being investigated, from immunomodulatory agents to adoptive cell therapy, bispecific T-cell engagers, oncolytic virotherapy, and checkpoint inhibition. One of the most exciting immunotherapies recently FDA approved is the use of CD19 chimeric antigen receptor T cells for pre-B-cell acute lymphoblas ...[more]